VHCP Management II’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-14,005	Closed	-$1.52M	–	22
2016 Q4	$1.52M	Hold	14,005	–	–	0.73%	19
2016 Q3	$2.24M	Hold	14,005	–	–	1.15%	20
2016 Q2	$1.53M	Buy	+14,005	New	+$1.53M	0.92%	19